February 15 is World Cholangiocarcinoma Day 2024

World Cholangiocarcinoma (CCA) Day is an international effort to raise much-needed awareness of CCA, a devastating cancer that occurs in the bile ducts in or outside the liver. #WorldCCADay
Get Involved

Introducing the Global Cholangiocarcinoma Alliance

The Global Cholangiocarcinoma Alliance (GCA) has united to establish a global voice in cholangiocarcinoma (CCA) through community collaborations.
Learn moreShow your support

Primary Care Education Campaign

The Global Cholangiocarcinoma Alliance (GCA) has united to establish a global voice in cholangiocarcinoma (CCA) through community collaborations.
Resources

Patient Information Sheets

Provided by the European Cholangiocarcinoma Network, follow the link for patient information sheets on capecitabine, FOLFOX, CAPOX, gemcitabine and cisplatin-gemcitabine in 7 different languages.
Patient information sheets

Did you miss our webinar on ICD-11 coding for CCA?

You can catch up on the presentations, as well as the live question and answer sessions, for free. Click on the link below to access all the resources.
Resources

Make a difference today and beyond

Sign the Global Cholangiocarcinoma Alliance (GCA) Pledge to support us in establishing a global voice in cholangiocarcinoma (CCA).
Sign the pledgeMeet the alliance
Logo image of faces

What is cholangiocarcinoma?

CHOLANGIOCARCINOMA FACTS


Cholangiocarcinoma (CCA), or bile duct cancer, is a primary liver cancer which arises within the biliary system



Cholangiocarcinoma (CCA) is very difficult to detect and diagnose
The incidence of cholangiocarcinoma
(CCA) is increasing
around the world, and the age of those affected is decreasing
Find out more

You can make a difference today by signing the pledge to support us in establishing a global voice in cholangiocarcinoma (CCA) and ensure our vision becomes a reality.

Sign the pledge
Tribute
Headshot of Professor Narong.

We are deeply saddened to share the news that Professor Narong Khuntikeo has recently passed. Narong will be greatly missed by all that knew him, and his passing is an immense loss to the global cholangiocarcinoma community.

“Professor Narong Khuntikeo worked at Khon Kaen University, Thailand, for 40 years. He was a pioneering liver surgeon who dedicated his life to educating and helping the population of the Isan region, northeast Thailand, as well as the people of Southeast Asia. Working within his homeland and also internationally, Professor Narong was instrumental in drawing attention to liver fluke related cholangiocarcinoma (CCA), specifically due to infection by Opisthorchis viverrini, which is increasing in incidence in Thailand, as well as in Myanmar, Lao PDR, Cambodia and southern Vietnam. CCA incidence is also increasing globally via the closely related liver fluke species, Opisthorchis felineus, found in eastern Europe and Russia, and Clonorchis sinensis distributed from northern Vietnam throughout China and Korea. Professor Narong also played a significant role in the establishment and development of the Cholangiocarcinoma Screening and Care Program (CASCAP) and spent many years working with the CASCAP team to screen people living around the Isan region, as well as throughout Thailand, for liver fluke infection and CCA. Together with colleagues, Professor Narong has extended the CASCAP into Lao PDR, with future establishment of the CASCAP planned in other Southeast Asian countries. I speak on behalf of the whole Global Cholangiocarcinoma Alliance (GCA) committee when I say that Professor Narong Khuntikeo’s passing is an immense loss to the global CCA community and that he will be greatly missed.”

Professor Ross H Andrews, Cholangiocarcinoma Research Institute (CARI), Khon Kaen University, Thailand and GCA Co-Chair

“Professor Narong Khuntikeo spent his life not only working as a world-leading liver surgeon, but also committed to educating people about cholangiocarcinoma (CCA). His passing is an immense loss to the global CCA community.”
Helen Morement, CEO AMMF and GCA Co-Chair
“Professor Narong Khuntikeo will be deeply missed by all that knew him, including colleagues at the Faculty of Medicine, Khon Kaen University (KKU), the Cholangiocarcinoma Screening and Care Program (CASCAP) team, the Cholangiocarcinoma Research Institute (CARI) team at KKU, Thailand, as well as the Global Cholangiocarcinoma Alliance (GCA) community. We are continuing and expanding existing programs focused on Professor Narong Khuntikeo’s life-saving work to reduce the incidence of cholangiocarcinoma (CCA) and improve life expectancy and quality of life of people within Southeast Asia as well as worldwide.”
Associate Professor Watcharin Loilome, Assistant Professor Attapol Titapun MD, Cholangiocarcinoma Research Institute (CARI), the CCA Foundation Thailand, and the CCA Excellence Centre, Faculty of Medicine, Khon Kaen University, Thailand.

Thank you to the funders of GCA.
All content is developed independently by AXON in collaboration with an expert steering committee; funders are allowed no influence on the content of GCA.